MDS
Myelodysplastic Syndrome (MDS) is a relatively uncommon disease, with only 15-20,000 new cases being diagnosed annually in the United States. As a result, no single hematologist sees a sufficient number of patients for conducting clinical trials or detailed molecular studies. Our group is unique in that through single-minded dedication to this field for the last two decades, we have built a National referral base for MDS treatment and research with a large enough patient population for meaningful clinical trials.

Patients travel from all over the country to participate in the latest clinical trials for their MDS and in molecular and genetic studies of their bone marrows which sheds more light on their particular form of the disease and allows for individualized modalities. The result is that our group has been caring for 500-600 MDS patients annually for the past decade, making it the largest MDS Center in the country.

View Myelodysplastic Syndrome Clinical Trials

Leukemia
There are an estimated 30,000 new cases of Leukemia each year in the United States. Reseach is increasing what we know about Leukemia, including the cause of the disease and better ways to treat people who have the disease. SVCCC has clinical trials available for patients who are eligible for these novel modalities.

View Leukemia Clinical Trials

Learn about the study of natural substances in the prevention and treatment of MDS

Bone Marrow Translational Research Laboratory